One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Lactose Intolerance Treatment Market

乳糖不耐症の治療市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2027年


[ 英語タイトル ] Global Lactose Intolerance Treatment Market Research Report—Forecast till 2027


Product Code : Market Research FutureHC00115169
Survey : Market Research Future
Publish On : September, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4450 / Question Form
Enterprise User USD6250 / Question Form
Abbott (US)., Nestlé (Switzerland), Cargill, Incorporated (US), Dean Foods (US), and Johnson & Johnson Services, Inc. (US)

[Report Description]

Global Lactose Intolerance Treatment Market Research Report—Forecast till 2027

Market Synopsis
As per the market research future analysis, the Global Lactose Intolerance Treatment Market is expected to register a CAGR of 6.29% during the assessment period of 2020 to 2027 to reach USD 42,783.32 Million by 2027. Lactose intolerance is an illness in which patient can not digest sugar in milk that causes diarrhoea, gas and bloating after eating or drinking dairy products.
The global lactose intolerance treatment market is expected to witness a healthy market growth during the review period. The lactose intolerance illness is of four main types of as primary lactase deficiency, secondary lactase deficiency, congenital lactase deficiency, and developmental lactase deficiency. According to the journal of health, population, and Nutrition published in 2017, the lactose intolerance incidences was higher in IBS-D patients as compared to healthy people.
Market Segmentation
Global Lactose Intolerance Treatment Market has been classified into Type, Treatment, Form, and End User.
Based on the type segment, Global Lactose Intolerance Treatment Market has been categorized into primary lactose intolerance, secondary lactose intolerance, congenital lactose intolerance. Primary lactose intolerance dominated the market in 2019. Primary lactose intolerance has a high prevalence rate as compared to others.
In terms of treatment the global market has been classified into food supplements, enzyme lactase supplements, probiotics. The food supplements segment is expected to dominate the market due to the largest market share in 2019. The growing adoption of Lactose-free products is fuelling the market growth of this segment.
By form segment, the market has been divided into powder, liquid, tablet. The powder segment held the largest market in 2019. Based on end user segment the global lactose intolerance treatment market has been categorized into homecare, hospitals and clinics, and others. The homecare segment is expected to lead the market during the forecast period owing to the largest share with a CAGR of 6.04% in 2019.
Regional Analysis
Geographically, the Global Lactose Intolerance Treatment Market has been studied across the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is likely to command the market during the study period owing to the largest market share in 2019. The region has further been categorized into North America and Latin America with North America is further divided into the US and Canada. The regional market growth is driven by the increasing prevalence of lactose intolerance and product innovation.
The Europe is expected to register second largest market of global lactose intolerance followed by Asia Pacific. The regional market is attributed to the existence of favourable government initiatives, research and development activities, and business expansions by major players.
The lactose intolerance treatment market in Asia-Pacific is anticipated to register the highest market growth expansion during the study period owing to rising healthcare expenditure, distribution of chilled dairy products in China, India, and Australia, and increasing population suffering from lactose intolerance.
Major Players
The Key Players in the Global Lactose Intolerance Treatment Market are Abbott (US)., Nestlé (Switzerland), Cargill, Incorporated (US), Dean Foods (US), and Johnson & Johnson Services, Inc. (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.



TABLE OF CONTENT
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 INTRODUCTION 14
2.2 ASSUMPTIONS & LIMITATIONS 14
2.2.1 ASSUMPTIONS 14
2.2.2 LIMITATIONS 14
2.3 MARKET STRUCTURE 14
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS 15
3.2 DATA MINING 15
3.3 SECONDARY RESEARCH 16
3.4 PRIMARY RESEARCH 17
3.5 FORECASTING TECHNIQUES 19
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 20
3.6.1 BOTTOM-UP APPROACH 21
3.6.2 TOP-DOWN APPROACH 21
3.6.3 DATA TRIANGULATION 22
3.6.4 VALIDATION 22
4 MARKET DYNAMICS
4.1 INTRODUCTION 23
4.2 DRIVERS 23
4.2.1 RISING CASES OF GASTROINTESTINAL DISORDERS 23
4.2.2 INCREASING AWARENESS ABOUT LACTOSE INTOLERANCE AND RELATED COMPLICATIONS 24
4.2.3 INCREASED PREVALENCE OF LACTOSE INTOLERANCE 24
4.3 RESTRAINTS 25
4.3.1 SIDE-EFFECTS ASSOCIATED WITH SUPPLEMENTS 25
4.4 OPPORTUNITIES 25
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS 26
5.1.1 R&D 26
5.1.2 MANUFACTURING 26
5.1.3 DISTRIBUTION & SALES 26
5.1.4 POST-SALES MONITORING 26
5.2 PORTER’S FIVE FORCES MODEL 27
5.2.1 THREAT OF NEW ENTRANTS 27
5.2.2 BARGAINING POWER OF SUPPLIERS 27
5.2.3 THREAT OF SUBSTITUTES 28
5.2.4 BARGAINING POWER OF BUYERS 28
5.2.5 INTENSE RIVALRY 28
5.3 INVESTMENT OPPORTUNITIES 28
6 LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
6.1 INTRODUCTION 29
6.2 PRIMARY LACTOSE INTOLERANCE 31
6.3 SECONDARY LACTOSE INTOLERANCE 31
6.4 CONGENITAL/DEVELOPMENTAL LACTOSE INTOLERANCE 32
7 LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
7.1 INTRODUCTION 33
7.2 FOOD SUPPLEMENTS 35
7.3 ENZYME LACTASE SUPPLEMENTS 35
7.4 PROBIOTICS 36
8 LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
8.1 INTRODUCTION 37
8.2 POWDER 39
8.3 LIQUID 39
8.4 TABLETS & CAPSULES 40
9 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET BY, END USER
9.1 INTRODUCTION 41
9.2 HOMECARE 43
9.3 HOSPITALS & CLINICS 43
10 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION
10.1 INTRODUCTION 44
10.2 AMERICAS 46
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.2.1 NORTH AMERICA 49
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.2.1.1 US 51
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.2.1.2 CANADA 53
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.2.2 LATIN AMERICA 55
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.3 EUROPE 58
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.3.1 WESTERN EUROPE 61
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.3.1.1 GERMANY 64
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.3.1.2 FRANCE 66
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.3.1.3 UK 68
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.3.1.4 ITALY 70
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.3.1.5 SPAIN 72
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.3.1.6 REST OF WESTERN EUROPE 74
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.3.2 EASTERN EUROPE 76
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.4 ASIA-PACIFIC 78
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.4.1 CHINA 81
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.4.2 AUSTRALIA 83
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.4.3 JAPAN 85
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.4.4 INDIA 87
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.4.5 SOUTH KOREA 89
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.4.6 REST OF THE ASIA-PACIFIC 91
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.5 MIDDLE EAST & AFRICA 93
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.5.1 MIDDLE EAST 96
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.5.2 AFRICA 98
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION 100
11.2 COMPANY SHARE ANALYSIS 100
12 COMPANY PROFILES
12.1 JOHNSON & JOHNSON SERVICES, INC. 101
12.1.1 COMPANY OVERVIEW 101
12.1.2 FINANCIAL OVERVIEW 101
12.1.3 PRODUCTS/SERVICES OFFERED 102
12.1.4 KEY DEVELOPMENTS 102
12.1.5 SWOT ANALYSIS 102
12.1.6 KEY STRATEGIES 102
12.2 NESTLÉ 103
12.2.1 COMPANY OVERVIEW 103
12.2.2 FINANCIAL OVERVIEW 103
12.2.3 PRODUCTS/SERVICES OFFERED 104
12.2.4 KEY DEVELOPMENTS 104
12.2.5 SWOT ANALYSIS 104
12.2.6 KEY STRATEGIES 105
12.3 ABBOTT 106
12.3.1 COMPANY OVERVIEW 106
12.3.2 FINANCIAL OVERVIEW 106
12.3.3 PRODUCTS/SERVICES OFFERED 106
12.3.4 KEY DEVELOPMENTS 107
12.3.5 SWOT ANALYSIS 107
12.3.6 KEY STRATEGIES 107
12.4 DEERLAND ENZYMES, INC. 108
12.4.1 COMPANY OVERVIEW 108
12.4.2 FINANCIAL OVERVIEW 108
12.4.3 PRODUCTS/SERVICES OFFERED 108
12.4.4 KEY DEVELOPMENTS 108
12.4.5 SWOT ANALYSIS 109
12.4.6 KEY STRATEGIES 109
12.5 RITTER PHARMACEUTICALS 110
12.5.1 COMPANY OVERVIEW 110
12.5.2 FINANCIAL OVERVIEW 110
12.5.3 PRODUCTS/SERVICES OFFERED 110
12.5.4 KEY DEVELOPMENTS 110
12.5.5 SWOT ANALYSIS 111
12.5.6 KEY STRATEGIES 111
12.6 GUARDIAN DRUG COMPANY 112
12.6.1 COMPANY OVERVIEW 112
12.6.2 FINANCIAL OVERVIEW 112
12.6.3 PRODUCTS/SERVICES OFFERED 112
12.6.4 KEY DEVELOPMENTS 112
12.6.5 SWOT ANALYSIS 113
12.6.6 KEY STRATEGIES 113
12.7 NOVOZYMES 114
12.7.1 COMPANY OVERVIEW 114
12.7.2 FINANCIAL OVERVIEW 114
12.7.3 PRODUCTS/SERVICES OFFERED 114
12.7.4 KEY DEVELOPMENTS 115
12.7.5 SWOT ANALYSIS 115
12.7.6 KEY STRATEGIES 115
12.8 CARGILL, INCORPORATED 116
12.8.1 COMPANY OVERVIEW 116
12.8.2 FINANCIAL OVERVIEW 116
12.8.3 PRODUCTS/SERVICES OFFERED 116
12.8.4 KEY DEVELOPMENTS 116
12.8.5 SWOT ANALYSIS 117
12.8.6 KEY STRATEGIES 117
12.9 ARLA FOODS 118
12.9.1 COMPANY OVERVIEW 118
12.9.2 FINANCIAL OVERVIEW 118
12.9.3 PRODUCTS/SERVICES OFFERED 119
12.9.4 KEY DEVELOPMENTS 119
12.9.5 SWOT ANALYSIS 119
12.9.6 KEY STRATEGIES 120
12.10 DEAN FOODS 121
12.10.1 COMPANY OVERVIEW 121
12.10.2 FINANCIAL OVERVIEW 121
12.10.3 PRODUCTS/SERVICES OFFERED 121
12.10.4 KEY DEVELOPMENTS 122
12.10.5 SWOT ANALYSIS 122
12.10.6 KEY STRATEGIES 122
13 APPENDIX
13.1 REFERENCES 123
13.2 RELATED REPORTS 123

LIST OF TABLES
TABLE 1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18
TABLE 2 GLOBAL LACTOSE INTOLERANCE TREATMENT, BY TYPE 2020–2027 (USD MILLION) 30
TABLE 3 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR PRIMARY LACTOSE INTOLERANCE, BY REGION 2020 & 2027 (USD MILLION) 31
TABLE 4 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR SECONDARY LACTOSE INTOLERANCE, BY REGION 2020 & 2027 (USD MILLION) 31
TABLE 5 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR CONGENITAL/DEVELOPMENTAL LACTOSE INTOLERANCE, BY REGION 2020 & 2027 (USD MILLION) 32
TABLE 6 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 34
TABLE 7 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR FOOD SUPPLEMENT, BY REGION 2020 & 2027 (USD MILLION) 35
TABLE 8 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR ENZYME LACTASE SUPPLEMENTS, BY REGION 2020 & 2027 (USD MILLION) 35
TABLE 9 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR PROBIOTICS, BY REGION 2020 & 2027 (USD MILLION) 36
TABLE 10 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 38
TABLE 11 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR POWDER, BY REGION 2020–2027 (USD MILLION) 39
TABLE 12 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR LIQUID, BY REGION 2020–2027 (USD MILLION) 39
TABLE 13 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR TABLETS/CAPSULES, BY REGION 2020–2027 (USD MILLION) 40
TABLE 14 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 42
TABLE 15 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR HOME CARE, BY REGION 2020–2027 (USD MILLION) 43
TABLE 16 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR HOSPITAL & CLINICS, BY REGION 2020–2027 (USD MILLION) 43
TABLE 17 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2020–2027 (USD MILLION) 44
TABLE 18 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2020–2027 (USD MILLION) 46
TABLE 19 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 47
TABLE 20 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 47
TABLE 21 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 48
TABLE 22 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 48
TABLE 23 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2020–2027 (USD MILLION) 49
TABLE 24 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 49
TABLE 25 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 50
TABLE 26 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 50
TABLE 27 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 51
TABLE 28 US: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 51
TABLE 29 US: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 52
TABLE 30 US: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 52
TABLE 31 US: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 53
TABLE 32 CANADA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 53
TABLE 33 CANADA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 54
TABLE 34 CANADA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 54
TABLE 35 CANADA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 55
TABLE 36 LATIN AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 55
TABLE 37 LATIN AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 56
TABLE 38 LATIN AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 56
TABLE 39 LATIN AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 57
TABLE 40 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2020–2027 (USD MILLION) 58
TABLE 41 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 59
TABLE 42 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 59
TABLE 43 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 60
TABLE 44 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 60
TABLE 45 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2020–2027 (USD MILLION) 61
TABLE 46 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 62
TABLE 47 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 62
TABLE 48 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 63
TABLE 49 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 63
TABLE 50 GERMANY: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 64
TABLE 51 GERMANY: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 64
TABLE 52 GERMANY: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 65
TABLE 53 GERMANY: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 65
TABLE 54 FRANCE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 66
TABLE 55 FRANCE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 66
TABLE 56 FRANCE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 67
TABLE 57 FRANCE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 67
TABLE 58 UK: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 68
TABLE 59 UK: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 68
TABLE 60 UK: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 69
TABLE 61 UK: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 69
TABLE 62 ITALY: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 70
TABLE 63 ITALY: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 70
TABLE 64 ITALY: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 71
TABLE 65 ITALY: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 71
TABLE 66 SPAIN: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 72
TABLE 67 SPAIN: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 72
TABLE 68 SPAIN: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 73
TABLE 69 SPAIN: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 73
TABLE 70 REST OF WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 74
TABLE 71 REST OF WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 74
TABLE 72 REST OF WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 75
TABLE 73 REST OF WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 75
TABLE 74 EASTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 76
TABLE 75 EASTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 76
TABLE 76 EASTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 77
TABLE 77 EASTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 77
TABLE 78 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2020–2027 (USD MILLION) 78
TABLE 79 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 79
TABLE 80 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 79
TABLE 81 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 80
TABLE 82 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 80
TABLE 83 CHINA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 81
TABLE 84 CHINA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 81
TABLE 85 CHINA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 82
TABLE 86 CHINA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 82
TABLE 87 AUSTRALIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 83
TABLE 88 AUSTRALIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 83
TABLE 89 AUSTRALIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 84
TABLE 90 AUSTRALIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 84
TABLE 91 JAPAN: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 85
TABLE 92 JAPAN: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 85
TABLE 93 JAPAN: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 86
TABLE 94 JAPAN: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 86
TABLE 95 INDIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 87
TABLE 96 INDIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 87
TABLE 97 INDIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 88
TABLE 98 INDIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 88
TABLE 99 SOUTH KOREA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 89
TABLE 100 SOUTH KOREA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 89
TABLE 101 SOUTH KOREA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 90
TABLE 102 SOUTH KOREA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 90
TABLE 103 REST OF THE ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 91
TABLE 104 REST OF THE ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 91
TABLE 105 REST OF THE ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 92
TABLE 106 REST OF THE ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 92
TABLE 107 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2020–2027 (USD MILLION) 93
TABLE 108 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 94
TABLE 109 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 94
TABLE 110 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 95
TABLE 111 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 95
TABLE 112 MIDDLE EAST: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 96
TABLE 113 MIDDLE EAST: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 96
TABLE 114 MIDDLE EAST: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 97
TABLE 115 MIDDLE EAST: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 97
TABLE 116 AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020–2027 (USD MILLION) 98
TABLE 117 AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020–2027 (USD MILLION) 98
TABLE 118 AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 99
TABLE 119 AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 99

LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS 13
FIGURE 2 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET: MARKET STRUCTURE 14
FIGURE 3 PRIMARY RESPONDENT’S BREAKDOWN 18
FIGURE 4 BOTTOM-UP AND TOP-DOWN APPROACH 20
FIGURE 5 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET 23
FIGURE 6 VALUE CHAIN: GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET 26
FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET 27
FIGURE 8 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020 (%) 29
FIGURE 9 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020 & 2027 (USD MILLION) 30
FIGURE 10 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020 (%) 33
FIGURE 11 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020 & 2027 (USD MILLION) 34
FIGURE 12 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020 (%) 37
FIGURE 13 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020–2027 (USD MILLION) 38
FIGURE 14 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020 (%) 41
FIGURE 15 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 42
FIGURE 16 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION2020–2027 (USD MILLION) 45
FIGURE 17 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2020 (%) 45
FIGURE 18 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2020 (%) 46
FIGURE 19 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2020 (%) 49
FIGURE 20 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2020 (%) 58
FIGURE 21 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2020 (%) 61
FIGURE 22 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2020 (%) 78
FIGURE 23 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2020 (%) 93
FIGURE 24 GLOBAL LACTOSE INTOLERANCE TREATMENT MAJOR PLAYERS MARKET SHARE ANALYSIS, 2020 (%) 100

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+